CirrusDx Laboratory receives emergency use authorisation from FDA for COVID-19 testing
CirrusDx validated and will commercialize the Allplex™ 2019-nCoV Assay, a real-time Reverse Transcriptase PCR test developed by Seegene,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Apr 20
CirrusDx validated and will commercialize the Allplex™ 2019-nCoV Assay, a real-time Reverse Transcriptase PCR test developed by Seegene,…
17 Apr 20
The Vent Multiplexor is a patent-pending device designed to provide individualized emergency crisis care for two adult patients…
16 Apr 20
In general, the TransAeris Diaphragmatic Pacing (DP) functions with temporary small electrodes implanted by minimally invasive surgery to…
16 Apr 20
The Coala Heart Monitor makes it possible for home quarantined patients to easily monitor their heart and record…
Experts on ventilator regulation in the US and UK weigh in on what relevant bodies have done to…
15 Apr 20
SonoVision is claimed to be the first machine-learning enabled ultrasound product for intraoperative access to the spine
15 Apr 20
This next generation INS decreases how frequently a patient needs to recharge their implanted device to once a…
14 Apr 20
The EUA status enables the immediate use of saliva in COVID-19 testing exclusively applying the Spectrum SDNA-1000 saliva…
14 Apr 20
Orig3n's test will help in the qualitative detection of nucleic acid from SARS-CoV-2 in oropharyngeal, nasopharyngeal, anterior nasal,…
13 Apr 20
The EUA status will allow to use the blood purification system to treat patients aged 18 year and…